help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westphal, V.
Right arrow Articles by Freeze, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westphal, V.
Right arrow Articles by Freeze, H. H.
(American Journal of Pathology. 2000;157:1917-1925.)
© 2000 American Society for Investigative Pathology


Regular Articles

Reduced Heparan Sulfate Accumulation in Enterocytes Contributes to Protein-Losing Enteropathy in a Congenital Disorder of Glycosylation

Vibeke Westphal*, Simon Murch{dagger}, Soohyun Kim*, Geetha Srikrishna*, Bryan Winchester{ddagger}, Richard Day§ and Hudson H. Freeze*

From the The Burnham Institute,*
La Jolla, California; the University Department of Paediatric Gastroenterology,{dagger}
Royal Free and University College School of Medicine, London, United Kingdom; the Institute of Child Health,{ddagger}
University College, London, United Kingdom; and St. Mark’s Hospital,§
Harrow, United Kingdom

Intestinal biopsy in a boy with gastroenteritis-induced protein-losing enteropathy (PLE) showed loss of heparan sulfate (HS) and syndecan-1 core protein from the basolateral surface of the enterocytes, which improved after PLE subsided. Isoelectric focusing analysis of serum transferrin indicated a congenital disorder of glycosylation (CDG) and subsequent analysis showed three point mutations in the ALG6 gene encoding an {alpha}1,3-glucosyltransferase needed for the addition of the first glucose to the dolichol-linked oligosaccharide. The maternal mutation, C998T, causing an A333V substitution, has been shown to cause CDG-Ic, whereas the two paternal mutations, T391C (Y131H) and C924A (S308R) have not previously been reported. The mutations were tested for their ability to rescue faulty N-linked glycosylation of carboxypeptidase Y in an ALG6-deficient Saccharomyces cerevisiae strain. Normal human ALG6 rescues glycosylation and A333V partially rescues, whereas the combined paternal mutations (Y131H and S308R) are ineffective. Underglycosylation resulting from each of these mutations is much more severe in rapidly dividing yeast. Similarly, incomplete protein glycosylation in the patient is most severe in rapidly dividing enterocytes during gastroenteritis-induced stress. Incomplete N-linked glycosylation of an HS core protein and/or other biosynthetic enzymes may explain the selective localized loss of HS and PLE.





This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. M. Ostrow, H. Freeze, and J. Rychik
Protein-Losing Enteropathy After Fontan Operation: Investigations Into Possible Pathophysiologic Mechanisms
Ann. Thorac. Surg., August 1, 2006; 82(2): 695 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Bode, S. Murch, and H. H. Freeze
Heparan Sulfate Plays a Central Role in a Dynamic in Vitro Model of Protein-losing Enteropathy
J. Biol. Chem., March 24, 2006; 281(12): 7809 - 7815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Bode, E. A. Eklund, S. Murch, and H. H. Freeze
Heparan sulfate depletion amplifies TNF-{alpha}-induced protein leakage in an in vitro model of protein-losing enteropathy
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1015 - G1023.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Westphal, S. Kjaergaard, E. Schollen, K. Martens, S. Grunewald, M. Schwartz, G. Matthijs, and H. H. Freeze
A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency
Hum. Mol. Genet., March 1, 2002; 11(5): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H. H. Freeze
Update and perspectives on congenital disorders of glycosylation
Glycobiology, December 1, 2001; 11(12): 129R - 143R.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.